Should patients with systemic sclerosis-related pulmonary arterial hypertension be anticoagulated?

Nikpour, M; Stevens, W; Proudman, S M; Buchbinder, R; Prior, D; Zochling, J; Williams, T; Gabbay, E; Nandurkar, H

Nikpour, M; Stevens, W; Proudman, S M; Buchbinder, R; Prior, D; Zochling, J; Williams, T; Gabbay, E; Nandurkar, H.

Affiliation

Nikpour M; Department of Medicine, St Vincent's Academic Centre, The University of Melbourne, Melbourne, Victoria, Australia. mnikpour@medstv.unimelb.edu.au

Intern Med J ; 43(5): 599-603, 2013 May.

Article in En | MEDLINE | ID: mdl-23668273

Subject(s)

Anticoagulants/therapeutic use; Hypertension, Pulmonary/drug therapy; Hypertension, Pulmonary/epidemiology; Scleroderma, Systemic/drug therapy; Scleroderma, Systemic/epidemiology; Familial Primary Pulmonary Hypertension; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Scleroderma, Systemic / Hypertension, Pulmonary / Anticoagulants Type of study: Clinical_trials / Observational_studies Limits: Humans Language: En Journal: Intern Med J Journal subject: MEDICINA INTERNA Year: 2013 Type: Article Affiliation country: Australia

Fulltext

XML

PubMed Links

Search on Google